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Particles of cowpea mosaic virus (CPMV) have enjoyed considerable success as nano-
particles. The development of a system for producing empty virus-like particles (eVLPs)
of the virus, which are non-infectious and have the potential to be loaded with heterol-
ogous material, has increased the number of possible applications for CPMV-based parti-
cles. However, for this potential to be realised, it was essential to demonstrate that
eVLPs were accurate surrogates for natural virus particles, and this information was pro-
vided by high-resolution cryo-EM studies of eVLPs. This demonstration has enabled the
approaches developed for the production of modiﬁed particles developed with natural
CPMV particles to be applied to eVLPs. Furthermore, a combination of cryo-EM and
mutagenic studies allowed the development of particles which are permeable but which
could still assemble efﬁciently. These particles were shown to be loadable with cobalt,
indicating that they can, indeed, be used as nano-containers.
Introduction
Cowpea mosaic virus (CPMV) has a long history of use in biotechnology and nanotechnology [1]. All
or parts of its RNA genome have been used to create systems for the expression of proteins in plants
and its particles have been developed for such applications as epitope display and bioimaging [2–4].
The particles, which consist of 60 copies each of the large (L) and small (S) coat proteins produced
via processing of a common precursor (VP60), are particularly suited to these applications as they are
highly regular, very robust and can be modiﬁed both genetically and chemically. Furthermore, they
have been shown to be biocompatible and therefore suitable for in vivo applications [5,6].
Traditionally, CPMV particles for biotechnology and nanotechnology were produced through
infecting plants with either wild-type (WT) or mutant versions of the virus. While this gives high
yields of particles, the majority of these (>90%) contain one or other of the two genomic RNAs
(RNA-1, 6 kb; RNA-2, 3.5 kb), with only a small proportion being natural empty particles (top com-
ponent). This can be a disadvantage since preparations retain infectivity unless speciﬁc inactivation
steps are taken, and there is limited capacity to load the particles with heterologous material. To
address this issue, transient expression has been used to co-express VP60 and the RNA-1-encoded
24K protease necessary for its processing. This results in the formation of particles, termed empty
virus-like particles (eVLPs), that are devoid of RNA [7]. Both cryo-electron microscopy (cryo-EM)
and crystallographic analysis [8,9] showed that the bulk of the particle structure was identical with
that of virus particles produced by infection [8,10,11]; indeed, a cryo-EM reconstruction of eVLPs has
recently been produced at a global resolution of 2.7 Å (Figure 1). The only signiﬁcant difference
between the structures of eVLPs and natural virus particles occurs at the C-terminus of S protein
where additional amino acids can be resolved in the case of eVLPs; this is a region of 24 amino acids
that is often cleaved from mature particles. Overall, these results suggested that eVLPs could be
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effective substitutes for natural virus particles with the added advantage that they can potentially be loaded.
The sequence of VP60 can be readily genetically manipulated and mutant eVLPs can be produced through the
co-inﬁltration of Nicotiana benthamiana with separate plasmids containing VP60 and the 24K protease or a
plasmid containing both sequences [12,13]. The purpose of this review is to assess progress in the use of eVLPs
for a variety of applications.
Peptide display on the surface of eVLPs
One of the early applications of CPMV particles produced via infection was epitope display [14,15]. This tech-
nology involved inserting sequences into exposed loops on the particle surface, the most commonly used one
being the βB–βC loop of the S coat protein, though it has proved possible to display peptides at other sites
Figure 1. Cryo-EM structure of CPMV eVLP at 2.7 Å resolution.
(a) EM density map of CPMV eVLP determined by cryo-EM to a global resolution of 2.7 Å. (EMD-3952). The large (L) subunit is
displayed in green and the small (S) subunit in blue. Five S subunits interact to form turrets at the ﬁve-fold axis. (b) Example
electron microscopy (EM) density from the cryo-EM reconstruction. (c) Fourier Shell correlation (FSC) of masked map,
unmasked map, corrected map and phase-randomised map. The resolution reported here was according to the 0.143 criterion.
Images produced using ChimeraX UCSF (Goddard et al. [27]), Pymol (Schrodinger [28]) and RELION2.0 (Kimanium et al. [29]).
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within both the L and S proteins [16,17]. The chimaeras were shown to be able to elicit the production of anti-
bodies against the inserted sequence in a range of experimental animals and, in the case of a chimaera expres-
sing an epitope from Mink enteritis virus, to be able to confer protective immunity in target animals [18].
Crystallographic analysis of the structure adopted by an epitope from human rhinovirus when presented at dif-
ferent positions on the CPMV surface also enabled correlations to be made between the mode of presentation
and the antibody response elicited [19,20].
Despite these successes, chimaeras based on infectious CPMV suffer from several disadvantages. The modi-
ﬁed particles could potentially spread in the environment, there were limits to the nature of the sequences that
could be expressed on the particle surface before infectivity was lost [21] and there was tendency of the insert
to be cleaved at its C-terminus [22]. In particular, there was a tendency of chimaeric particles to form large
aggregates within infected cells, and it proved difﬁcult or impossible to propagate and purify chimaeras con-
taining inserts with a high pI [21] unless the overall positive charge on the particle was reduced by the inclu-
sion of acidic amino acids [12]. Clearly, the lack of genomic RNA within eVLPs addresses the issue of
infectivity, but it was of considerable interest to determine if the use of eVLPs for display could provide a solu-
tion to the other issues as well. Therefore, a series of chimaeras was created in which a range of peptides with
variable length and charge were inserted into the βB–βC loop of the S coat protein and the yield of the result-
ant eVLP-based chimaeras assessed (Table 1). The results showed that the yield of chimaeras varied greatly
depending on the nature of the peptide inserted, with certain chimaeras giving yields comparable to unmodi-
ﬁed eVLPs (0.2–0.3 g/kg leaf wet weight) and others giving barely detectable numbers of particles (<0.01 g/kg).
These ﬁndings indicate that the use of eVLPs as opposed to infectious virus does not overcome variability of
yields found previously [21]. Analysis of the proteins contained within the modiﬁed eVLPs suggested that
cleavage at the C-terminus of the insert occurs less extensively than had previously been observed with virus
particles, with the majority of eVLP-based particles being isolated with an uncleaved loop. The most likely
explanation for this is the difference in host used for propagation of eVLPs (N. benthamiana) and infectious
virus (Vigna unguiculata) as cleavage of the C-terminus of the S protein also appears to be more rapid in the
latter host.
Modifying the permeability of eVLPs
Given the fact that they contain no encapsidated RNA, it was anticipated that it should be straightforward to
load eVLPs with foreign material, especially since natural empty particles produced via infection (top compo-
nent) had been successfully loaded with metal and metal oxide [23]. Surprisingly, eVLPs were refractory to
loading with metals unless ﬁrst treated with chymotrypsin to remove the C-terminal residues of the S protein
[24,25], though some limited permeability to dye molecules could be observed, probably as a result of partial
cleavage of the C-terminus of the S protein [26]. Attempts to delete this entire region genetically to obviate the
need for enzyme treatment drastically reduced particle formation [8,24]; sequential deletion of parts of the
sequence from the C-terminus either allowed the formation of particles that were impenetrable to negative
Table 1 Properties of eVLP-based chimaeras
Short RGD-containing integrin-targeting peptides and non-RGD tumour-targeting peptides of differing lengths and pI
were inserted into the βB–βC loop of S coat protein. Where present, the RGD sequence is shown in bold. The effect of
the insert on the yield and assembly or recombinant particles was assessed allowing the chimaeras to be divided into
two categories.
High yield/good assembly Poor yield/assembly problems
TSYNRGDSTFESK (Fibrinogen α-chain) pI 5.73 GSFGRGDSDEWTF λ-receptor on Escherichia coli pI 4.03
GVGGRGDSGRPIM (Sindbis virus coat protein) pI 9.6 ACMGRGDSGGSWI α-lytic protease pI 5.87
VNTANST (tumour-targeting mini-peptide) pI 5.49 LTVSPWY (tumour-targeting mini-peptide) pI 5.52
VPNLRGDLQVLAQ (FMDV) pI 5.81 LFHLFIYI (tumour-targeting peptide) pI 6.3
RGD pI 5.84 SVVYGRL pI 8.46
NGR pI 9.75 SVSVGMKPSPRP pI 11.0
LDVP (integrin-binding ligand) pI 3.8 CDCRGDCFC pI 4.2
GRGDNP (integrin-binding site) pI 5.84 YPHYSLPGSSTL pI 6.74
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staining or abolished particle assembly (Table 2). Analysis of the cryo-EM structure revealed that the portion of
the C-terminal sequence proximal to the main part of the particle makes inter-subunit interactions that play a
crucial role in the early stages of particle formation [8] explaining why deletion of the entire 24 amino acids
abrogates particle formation.
In an attempt to produce eVLPs that can assemble yet are permeable, a series of additional mutants were
created, concentrating on the region where cleavage occurs (between L189 and L190 of the S protein; Table 2).
As with the deletion mutants, most of the mutations either abolished assembly or led to the formation of parti-
cles which were as impermeable as wild-type eVLPs. The exception was mutant L189G in which the last amino
acid visible in the cleaved form of the S protein was mutated to glycine. This mutant gave wild-type levels of
particles which appeared to stain-penetrable (Figure 2). To conﬁrm the permeability of the L189G mutant par-
ticles, they were subjected to the cobalt-loading protocol previously applied successfully to CPMV top compo-
nent and chymotrypsin-treated eVLPs [23,24]. Transmission electron microscopy in the absence of negative
stain revealed that cobalt could be successfully deposited within the L189G particles, indicating that such muta-
tions could be a route to making permeable, and therefore loadable, eVLPs, obviating the need for protease
digestion.
The exact position of L189 in the eVLP structure is unknown, as residues 184–189 are not visible in the
atomic model derived from the cryo-EM reconstruction [8]. However, the approximate position can be
deduced as L190 is visible and the EM density for the amino acid backbone can be visualised. We predict that
the hydrophobic leucine side chain is usually buried in the protein structure and therefore shielded from the
external environment, stabilising the structure of the S subunit C-terminus. We predict that the L189G muta-
tion weakens this hydrophobic interaction and increases the ﬂexibility of the whole C-terminus. This increased
ﬂexibility reveals a large pore allowing access to the interior of the capsid (Figure 3). Despite increasing
C-terminal ﬂexibility and allowing access to the interior of particle, the L189G substitution does not abolish the
Table 2 Characteristics of deletion and substitution mutants in the 24 amino acid
cleavable C-terminus of S coat protein of CPMV eVLPs (cleavage after L189 is
indicated by /)
The effect of the mutations on particle yield and permeability are shown with WT, indicating
that the yield and/or permeability of the particles was similar to that of particles with an
intact C-terminus (WT). Permeability was assessed by the ability of the negative stain to
penetrate the particles. Abbreviations: N/D: not determined due to the low yield of particles.
L189G is shown in bold as it gives a WT yield of permeable particles.
Mutant Yield Permeability Reference
WT
L/LKFRFRDIERSKRSVMVGHTATAA
WT WT [8]
C-termΔ7
L/LKFRFRDIERSKRSVMV
WT WT [8]
C-termΔ11
L/LKFRFRDIERSKR
WT WT [8]
C-termΔ14
L/LKFRFRDIER
Very low N/D [8]
C-termΔ16
L/LKFRFRDI
Very low N/D [8]
C-termΔ24
L/
Very low N/D [8]
ΔL189–190 Very low Enhanced This report
ΔL189 WT WT This report
L189I WT WT This report
L189G WT Enhanced This report
L189G/L190G Very low N/D This report
L189F/L190F Moderate WT This report
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C-terminal interactions necessary for particle formation [8]. The ability to produce high levels of permeable
capsids without the need for enzymatic treatment should promote the take up of eVLPs as nano-containers.
Conclusions
The availability of a non-infectious form of CPMV particles (eVLPs) has opened new possibilities for the use
of such particles in biotechnology and nanotechnology. However, a vital prerequisite for such new develop-
ments was the demonstration, by cryo-EM, that eVLPs are accurate structural mimics of natural CPMV parti-
cles. Such studies also informed the development of permeable capsids for loading purposes. Future studies
Figure 2. TEM of enhanced permeability mutants ΔL189-190 and L189G and WT eVLPs.
The permeability of the particles assessed by the extent of penetration of the 2% (w/v) uranyl acetate negative stain (upper
images) and loading of L189G particles with cobalt (lower image).
Figure 3. Cryo-EM reconstruction of eVLP, with a Gaussian ﬁlter to 2 Å applied.
A zoomed-in view of a CPMV turret (made up of ﬁve S subunits) showing a pore allowing access to the interior of CPMV
capsid. This pore is usually occluded by the C-terminal of S subunit. We propose that the ﬂexibility of this region is increased
with the L189G mutation. The approximate position of Leucine 189 in the eVLP is indicated.
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may also make use of cryo-EM technology to analyse the structures of derivatised versions of eVLPs, once
more underlining the beneﬁt of combined genetic and structural studies.
Database depositions
Cryo-EM reconstruction of CPMV eVLP is deposited in the EM Data Bank under accession code EMD-3952.
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